Correlation Between Pfizer and Descartes Systems

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Descartes Systems at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Descartes Systems into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc CDR and Descartes Systems Group, you can compare the effects of market volatilities on Pfizer and Descartes Systems and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Descartes Systems. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Descartes Systems.

Diversification Opportunities for Pfizer and Descartes Systems

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and Descartes is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and Descartes Systems Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Descartes Systems and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with Descartes Systems. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Descartes Systems has no effect on the direction of Pfizer i.e., Pfizer and Descartes Systems go up and down completely randomly.

Pair Corralation between Pfizer and Descartes Systems

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the Descartes Systems. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc CDR is 1.02 times less risky than Descartes Systems. The stock trades about -0.05 of its potential returns per unit of risk. The Descartes Systems Group is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  12,407  in Descartes Systems Group on September 1, 2024 and sell it today you would earn a total of  4,103  from holding Descartes Systems Group or generate 33.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc CDR  vs.  Descartes Systems Group

 Performance 
       Timeline  
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Pfizer is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Descartes Systems 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Descartes Systems Group are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Descartes Systems displayed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Descartes Systems Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Descartes Systems

The main advantage of trading using opposite Pfizer and Descartes Systems positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Descartes Systems can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Descartes Systems will offset losses from the drop in Descartes Systems' long position.
The idea behind Pfizer Inc CDR and Descartes Systems Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios